On the move?  by unknown
iments looking into the long-term effect of SLAC both as a
stand-alone and perhaps as an adjunctive procedure and also
looking into modifications of the technique, looking forward to an
off-pump method of doing a similar kind of repair.
Dr Grossi. Please comment on the drastic, either 30% or 50%,
decrease in the septal-lateral suture length that was necessary to
achieve the desired clinical effect. In off-pump ischemic MR
patients in whom we are both elevating the annulus and the inferior
wall using the Myocor Coapsys device, we are typically only
having to decrease this distance 15% to 20%. Why do you think
you have to pull up so much further here to get rid of the MR than
what we have to do in study patients?
Dr Tibayan. That’s a very perceptive observation, Dr Grossi.
I think the reason for that is because, as a lot of investigators have
shown, chronic ischemic MR results not only from annular dilation
but also the displacement of the papillary muscle, specifically
lateral displacement of the posterior papillary muscle. I think for
the SLAC to be effective it has to address not only the septal-
lateral annular diameter but also correct at least in part this lateral
posterior papillary muscle displacement because a lot of annular
reduction isn’t going to get you too far if the papillary muscles are
still sitting out here causing leaflet tenting. So I think we had to
keep cinching down until the papillary muscle was dragged in
somewhat indirectly by means of mechanical continuity of the LV
between the annulus and the papillary muscle. Of course the
reason, as you pointed out, that the Coapsys device probably, I’m
guessing, requires less annular reduction is that it has a second foot
that is directly moving in the papillary muscle.
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